KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Non-Current Debt (2016 - 2021)

Historic Non-Current Debt for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q4 2021 value amounting to $675.7 million.

  • Alnylam Pharmaceuticals' Non-Current Debt rose 25325.39% to $675.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $675.7 million, marking a year-over-year increase of 25325.39%. This contributed to the annual value of $675.7 million for FY2021, which is 25325.39% up from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Non-Current Debt stood at $675.7 million for Q4 2021, which was up 25325.39% from $191.3 million recorded in Q4 2020.
  • In the past 5 years, Alnylam Pharmaceuticals' Non-Current Debt ranged from a high of $675.7 million in Q4 2021 and a low of $30.0 million during Q4 2017
  • Over the past 5 years, Alnylam Pharmaceuticals' median Non-Current Debt value was $30.0 million (recorded in 2017), while the average stood at $127.2 million.
  • In the last 5 years, Alnylam Pharmaceuticals' Non-Current Debt crashed by 8000.0% in 2018 and then skyrocketed by 25325.39% in 2021.
  • Over the past 5 years, Alnylam Pharmaceuticals' Non-Current Debt (Quarter) stood at $30.0 million in 2017, then changed by 0.0% to $30.0 million in 2018, then changed by 0.0% to $30.0 million in 2019, then surged by 537.59% to $191.3 million in 2020, then soared by 253.25% to $675.7 million in 2021.
  • Its Non-Current Debt stands at $675.7 million for Q4 2021, versus $191.3 million for Q4 2020 and $30.0 million for Q2 2019.